Abingdon Health Plc (ABDXF)
0.1981
0.00 (0.00%)
USD |
OTCM |
May 29, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 49.74M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 183.0% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 6.064 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Abingdon Health Plc engages in the development, manufacturing, and distribution of diagnostic devices and provides consultancy services to businesses in the diagnostics sector. It operates through the following segments: Contract Development Services, Contract Manufacturing, Products Sales, and Regulatory Services. The Contract Development Services segment refers to milestone-based development work for third parties. The Contract Manufacturing segment includes contract development. The Product Sales segment comprises the sale of AbC-19TM, Pocket Diagnostic products, PCRD tests, and antibodies for research use. The Regulatory Services segment involves customer support for compliance requirements in international IVD and medical device markets. The company was founded by Brett David Pollard, Chris Henry Francis Yates, and Christopher William Hand on January 16, 2008 and is headquartered in York, the United Kingdom. |
| URL | http://www.abingdonhealth.com |
| Investor Relations URL | N/A |
| HQ State/Province | York |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Abingdon Health Plc engages in the development, manufacturing, and distribution of diagnostic devices and provides consultancy services to businesses in the diagnostics sector. It operates through the following segments: Contract Development Services, Contract Manufacturing, Products Sales, and Regulatory Services. The Contract Development Services segment refers to milestone-based development work for third parties. The Contract Manufacturing segment includes contract development. The Product Sales segment comprises the sale of AbC-19TM, Pocket Diagnostic products, PCRD tests, and antibodies for research use. The Regulatory Services segment involves customer support for compliance requirements in international IVD and medical device markets. The company was founded by Brett David Pollard, Chris Henry Francis Yates, and Christopher William Hand on January 16, 2008 and is headquartered in York, the United Kingdom. |
| URL | http://www.abingdonhealth.com |
| Investor Relations URL | N/A |
| HQ State/Province | York |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |